Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04266301
Brief Title: Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) (STIMULUS-MDS2)

First Submitted : January 21, 2020
First Submitted that Met QC Criteria : February 10, 2020
First Posted : February 12, 2020

Last Update Submitted that Met QC Criteria : December 2, 2021
Last Update Posted : December 3, 2021